MBSR and MBCT: the two clinical programmes

Two programmes account for nearly all the clinical research on mindfulness. They are related, they are frequently confused, and they were built for different jobs.

Mindfulness-based stress reduction (MBSR)

Built for: people living with chronic illness, pain and stress, at a hospital that had run out of other things to offer them. Developed from 1979 at the University of Massachusetts Medical Center.

Shape: eight weekly group sessions of roughly two and a half hours, a full-day silent session around week six, and daily home practice of around forty-five minutes. The core components are the body scan, sitting meditation, mindful movement drawn from hatha yoga, and enquiry — group discussion of what practice actually threw up, rather than instruction.

Framing: deliberately secular and non-diagnostic. MBSR is a general programme, not a treatment for a named condition.

Where you find it: private courses, workplaces, some NHS and university settings. Provision is uneven and it is not a standard NHS offer.

Mindfulness-based cognitive therapy (MBCT)

Built for: preventing relapse in people with a history of recurrent depression. Developed in the 1990s by Zindel Segal, Mark Williams and John Teasdale, working from MBSR’s structure but adding cognitive therapy elements aimed at a specific mechanism.

The mechanism: in people who have been depressed before, low mood tends to reactivate habitual patterns of rumination and self-criticism, which is what pulls a dip down into an episode. MBCT trains people to notice that machinery starting and to relate to it differently rather than to argue with the content.

Shape: eight weekly group sessions, home practice, plus cognitive-therapy material — mood monitoring, work on thought patterns, and a personalised relapse-prevention plan.

Framing: explicitly a therapy for a defined clinical purpose, delivered to a defined group.

Where NICE stands

NICE’s guideline on depression in adults (NG222, 2022) considered relapse prevention and found good evidence that group CBT and MBCT were effective and, on average, cost-effective for people at high risk of relapse, with data covering treatment periods up to two years. The guideline recommends that people starting group CBT or MBCT for relapse prevention be offered a course with an explicit focus on relapse-prevention skills and on what is needed to stay well — usually eight sessions over two to three months, with the option of further sessions.

Read that recommendation precisely. It is about relapse prevention in people with a history of depression, and it sits alongside continued antidepressant treatment as an option, not above it. It is not a recommendation of mindfulness for depression in general, still less for wellbeing at large. NICE’s own rationale section sets out the reasoning.

Availability of MBCT within the NHS has been patchy for years, which is a separate and well-documented problem.

What a course actually asks of you

Both programmes are demanding, and this is consistently understated in the way they are marketed. Eight weeks of group attendance plus daily practice of thirty to forty-five minutes is a significant commitment, and the home practice is where most of the effect is presumed to come from. People who cannot do the practice do not get the dose that was studied.

Both are group programmes. Both involve turning attention towards difficult experience rather than away from it, which is uncomfortable by design and, for some people, more than uncomfortable — see what the trials show.

Choosing a teacher

Mindfulness teaching is not a regulated occupation in the UK and “mindfulness teacher” is not a protected title. Teacher-training pathways and good-practice guidelines exist, and it is reasonable to ask what training a teacher has completed, whether they have supervision, and whether they have their own established practice.

For anything offered as treatment rather than as a course, the check is the register — see how to check a practitioner.